Stock Analysts’ price target changes for Tuesday, September 22nd:
Abivax (NASDAQ:ABVX) had its price target cut by Wedbush from $140.00 to $118.00. Wedbush currently has a neutral rating on the stock.
Abivax (NASDAQ:ABVX) had its target price cut by Truist Financial Corporation from $155.00 to $151.00. They currently have a buy rating on the stock.
Alkermes (NASDAQ:ALKS) had its target price increased by Robert W. Baird from $58.00 to $61.00. The firm currently has an outperform rating on the stock.
Amrize (NYSE:AMRZ) had its price target reduced by UBS Group AG from $57.00 to $42.00. They currently have a neutral rating on the stock.
Anixa Biosciences (NASDAQ:ANIX) had its price target cut by HC Wainwright from $7.00 to $6.00. The firm currently has a buy rating on the stock.
Amphenol (NYSE:APH) had its price target boosted by BNP Paribas Exane from $107.50 to $110.00. They currently have an outperform rating on the stock.
Strive (NASDAQ:ASST) had its target price boosted by B. Riley Financial, Inc. from $26.00 to $33.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
Accsys Technologies (LON:AXS) had its target price reduced by Canaccord Genuity Group Inc. from GBX 130 to GBX 120. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
BitMine Immersion Technologies (NYSE:BMNR) had its target price boosted by B. Riley Financial, Inc. from $30.00 to $34.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
Henry Boot (LON:BOOT) had its price target trimmed by Berenberg Bank from GBX 219 to GBX 186. Berenberg Bank currently has a buy rating on the stock.
Chord Energy (NASDAQ:CHRD) had its price target cut by UBS Group AG from $189.00 to $184.00. UBS Group AG currently has a buy rating on the stock.
Celldex Therapeutics (NASDAQ:CLDX) had its price target increased by Cantor Fitzgerald from $61.00 to $72.00. The firm currently has an overweight rating on the stock.
Celldex Therapeutics (NASDAQ:CLDX) had its price target raised by HC Wainwright from $42.00 to $64.00. The firm currently has a buy rating on the stock.
Columbia Banking System (NASDAQ:COLB) had its target price reduced by Citigroup Inc. from $32.00 to $31.00. They currently have a neutral rating on the stock.
CRH (NYSE:CRH) had its target price lowered by UBS Group AG from $147.00 to $135.00. The firm currently has a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target reduced by Piper Sandler from $132.00 to $125.00. Piper Sandler currently has a neutral rating on the stock.
D.R. Horton (NYSE:DHI) had its target price trimmed by Keefe, Bruyette & Woods from $167.00 to $160.00. The firm currently has a market perform rating on the stock.
Elemental Royalty (NASDAQ:ELE) had its target price lowered by HC Wainwright from $33.00 to $31.00. They currently have a buy rating on the stock.
East West Bancorp (NASDAQ:EWBC) had its target price trimmed by Citigroup Inc. from $156.00 to $152.00. The firm currently has a buy rating on the stock.
Exelon (NASDAQ:EXC) had its target price reduced by Argus from $52.00 to $49.00. They currently have a buy rating on the stock.
Forward Industries (NASDAQ:FWDI) had its price target raised by B. Riley Financial, Inc. from $9.00 to $11.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
GRAIL (NASDAQ:GRAL) had its price target increased by Robert W. Baird from $96.00 to $118.00. Robert W. Baird currently has an outperform rating on the stock.
Hinge Health (NYSE:HNGE) had its price target raised by Robert W. Baird from $85.00 to $90.00. Robert W. Baird currently has a neutral rating on the stock.
Solana (NASDAQ:HSDT) had its price target increased by B. Riley Financial, Inc. from $3.50 to $4.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
Heartflow (NASDAQ:HTFL) had its price target boosted by Canaccord Genuity Group Inc. from $45.00 to $56.00. The firm currently has a buy rating on the stock.
Hancock Whitney (NASDAQ:HWC) had its target price lowered by Citigroup Inc. from $87.00 to $86.00. Citigroup Inc. currently has a buy rating on the stock.
Harworth Group (LON:HWG) had its price target trimmed by Berenberg Bank from GBX 202 to GBX 195. The firm currently has a buy rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price trimmed by JPMorgan Chase & Co. from $76.00 to $70.00. They currently have an overweight rating on the stock.
Kymera Therapeutics (NASDAQ:KYMR) had its price target boosted by Stifel Nicolaus from $132.00 to $152.00. They currently have a buy rating on the stock.
Lithia Motors (NYSE:LAD) had its price target reduced by Citigroup Inc. from $455.00 to $409.00. Citigroup Inc. currently has a buy rating on the stock.
Lennar (NYSE:LEN) had its price target reduced by Keefe, Bruyette & Woods from $85.00 to $75.00. They currently have an underperform rating on the stock.
Meta Platforms (NASDAQ:META) had its price target boosted by Jefferies Financial Group Inc. from $710.00 to $875.00. The firm currently has a buy rating on the stock.
Strategy (NASDAQ:MSTR) had its price target raised by B. Riley Financial, Inc. from $175.00 to $195.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
KindlyMD (NASDAQ:NAKA) had its price target increased by B. Riley Financial, Inc. from $11.00 to $13.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
Nextpower (NASDAQ:NXT) had its target price cut by Robert W. Baird from $156.00 to $116.00. They currently have an outperform rating on the stock.
Okta (NASDAQ:OKTA) had its target price increased by Robert W. Baird from $185.00 to $200.00. Robert W. Baird currently has an outperform rating on the stock.
Okta (NASDAQ:OKTA) had its target price increased by Scotiabank from $165.00 to $190.00. They currently have a sector outperform rating on the stock.
Old National Bancorp (NASDAQ:ONB) had its price target lowered by Citigroup Inc. from $31.00 to $30.00. The firm currently has a buy rating on the stock.
Prosperity Bancshares (NYSE:PB) had its price target trimmed by Citigroup Inc. from $79.00 to $77.00. Citigroup Inc. currently has a neutral rating on the stock.
Priority Technology (NASDAQ:PRTH) had its target price boosted by Keefe, Bruyette & Woods from $6.50 to $8.00. They currently have a market perform rating on the stock.
PTC Therapeutics (NASDAQ:PTCT) had its price target increased by Cantor Fitzgerald from $130.00 to $137.00. They currently have an overweight rating on the stock.
RxSight (NASDAQ:RXST) had its price target cut by Bank of America Corporation from $6.50 to $5.50. They currently have an underperform rating on the stock.
RxSight (NASDAQ:RXST) had its price target reduced by Jefferies Financial Group Inc. from $6.50 to $5.75. Jefferies Financial Group Inc. currently has a hold rating on the stock.
M&C Saatchi (LON:SAA) had its target price reduced by Berenberg Bank from GBX 195 to GBX 175. The firm currently has a buy rating on the stock.
SoundHound AI (NASDAQ:SOUN) had its target price trimmed by Piper Sandler from $7.00 to $6.00. The firm currently has a neutral rating on the stock.
Constellation Brands (NYSE:STZ) had its price target lowered by Barclays PLC from $132.00 to $122.00. They currently have an equal weight rating on the stock.
The Beauty Tech Group (LON:TBTG) had its price target increased by Canaccord Genuity Group Inc. from GBX 545 to GBX 600. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Twilio (NYSE:TWLO) had its price target increased by Rosenblatt Securities from $275.00 to $290.00. The firm currently has a buy rating on the stock.
Tyra Biosciences (NASDAQ:TYRA) had its price target reduced by HC Wainwright from $30.00 to $29.00. HC Wainwright currently has a buy rating on the stock.
Warner Bros. Discovery (NASDAQ:WBD) had its target price increased by Morgan Stanley from $29.00 to $31.00. The firm currently has an equal weight rating on the stock.
Xometry (NASDAQ:XMTR) had its target price raised by Rosenblatt Securities from $110.00 to $120.00. They currently have a buy rating on the stock.
Receive News & Ratings for Abivax SA Sponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abivax SA Sponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.
